Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Carcinoma, Non-Small-Cell Lung 73Lung Neoplasms 32Breast Neoplasms 19Head and Neck Neoplasms 16Neoplasms 11Glioblastoma 8Adenocarcinoma of Lung 8Squamous Cell Carcinoma of Head and Neck 7Colorectal Neoplasms 7Brain Neoplasms 7Adenocarcinoma, Bronchiolo-Alveolar 7Prostatic Neoplasms 6Neoplasm Metastasis 6Gliosarcoma 6Rectal Neoplasms 5Ovarian Neoplasms 5Colonic Neoplasms 5Esophageal Neoplasms 4Central Nervous System Neoplasms 4Carcinoma 4Unspecified Adult Solid Tumor, Protocol Specific 3Respiratory Tract Diseases 3Fallopian Tube Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Ovarian Epithelial 3Adenocarcinoma Of Esophagus 3Adenocarcinoma 3Urinary Bladder Neoplasms 2Thyroid Neoplasms 2Thyroid Carcinoma, Anaplastic 2

Interventions

Leucovorin 3Everolimus 3temsirolimus 2Trastuzumab 2Temozolomide 2Sirolimus 2Oxaliplatin 2Octreotide 2Melphalan 2Irinotecan 2Fluorouracil 2Capecitabine 2vatalanib 1tipifarnib 1regorafenib 1pazopanib 1napabucasin 1motesanib diphosphate 1irinotecan sucrosofate 1cixutumumab 1batifiban 1Vinorelbine 1Thalidomide 1Taxes 1Streptozocin 1Sorafenib 1Paclitaxel 1Interleukin-12 Subunit p35 1Interleukin-12 1High-Energy Shock Waves 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Carcinoma, Islet Cell × Gefitinib × Clear all
NCT00075439 2013-06-04

Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors

National Cancer Institute (NCI)

Phase 2 Completed
90 enrolled
Endocrine

Vipoma, Glucagonoma, Insulinoma, Somatostatinoma, Gastrinoma, Carcinoma, Islet Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡